The global market for Human Rabies Immunoglobulin (IM) was estimated to be worth US$ 396 million in 2023 and is forecast to a readjusted size of US$ 606.3 million by 2030 with a CAGR of 6.2% during the forecast period 2024-2030

Human Rabies Immunoglobulin (IM) - Market

Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.

Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization.

In this report, we study ERIG (Equine Rabies Immunoglobulin) and HRIG (Human Rabies Immunoglobulin)

Global Human Rabies Immunoglobulin (IM) key players include CSL Behring, Grifols, Sanofi, etc. Global top three manufacturers hold a share about 60%.

North America is the largest market, with a share over 30%, followed by China and Europe, both have a share about 45 percent.

In terms of product, HRIG is the largest segment, with a share over 85%. And in terms of application, the largest application is Category III Exposure, followed by Category II Exposure.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Rabies Immunoglobulin (IM), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Human Rabies Immunoglobulin (IM) by region & country, by Type, and by Application.

The Human Rabies Immunoglobulin (IM) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Rabies Immunoglobulin (IM).

Market Segmentation

Scope of Human Rabies Immunoglobulin (IM) - Market Report

Report Metric	Details
Report Name	Human Rabies Immunoglobulin (IM) - Market
Forecasted market size in 2030	US$ 606.3 million
CAGR	6.2%
Forecasted years	2024 - 2030
Segment by Type:	ERIG HRIG
Segment by Application	Category II Exposure Category III Exposure
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	CSL Behring, Grifols, Sanofi, Sichuan Yuanda Shuyang, CNBG, Kamada, CBPO, Shuanglin Bio, Weiguang Bio, Shanghai RAAS, Bharat Serum, VINS
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Human Rabies Immunoglobulin (IM) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Human Rabies Immunoglobulin (IM) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Human Rabies Immunoglobulin (IM) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Human Rabies Immunoglobulin (IM) - Market size in 2030?

Ans: The Human Rabies Immunoglobulin (IM) - Market size in 2030 will be US$ 606.3 million.

What is the market share of major companies in Human Rabies Immunoglobulin (IM) - Market?

Ans: Global top three manufacturers hold a share about 60%.

What is the Human Rabies Immunoglobulin (IM) - Market share by type?

Ans: In terms of product, HRIG is the largest segment, with a share over 85%.

Who are the main players in the Human Rabies Immunoglobulin (IM) - Market report?

Ans: The main players in the Human Rabies Immunoglobulin (IM) - Market are CSL Behring, Grifols, Sanofi, Sichuan Yuanda Shuyang, CNBG, Kamada, CBPO, Shuanglin Bio, Weiguang Bio, Shanghai RAAS, Bharat Serum, VINS

What are the Application segmentation covered in the Human Rabies Immunoglobulin (IM) - Market report?

Ans: The Applications covered in the Human Rabies Immunoglobulin (IM) - Market report are Category II Exposure, Category III Exposure

What are the Type segmentation covered in the Human Rabies Immunoglobulin (IM) - Market report?

Ans: The Types covered in the Human Rabies Immunoglobulin (IM) - Market report are ERIG, HRIG

1 Market Overview

1.1 Human Rabies Immunoglobulin (IM) Product Introduction

1.2 Global Human Rabies Immunoglobulin (IM) Market Size Forecast

1.2.1 Global Human Rabies Immunoglobulin (IM) Sales Value (2019-2030)

1.2.2 Global Human Rabies Immunoglobulin (IM) Sales Volume (2019-2030)

1.2.3 Global Human Rabies Immunoglobulin (IM) Sales Price (2019-2030)

1.3 Human Rabies Immunoglobulin (IM) Market Trends & Drivers

1.3.1 Human Rabies Immunoglobulin (IM) Industry Trends

1.3.2 Human Rabies Immunoglobulin (IM) Market Drivers & Opportunity

1.3.3 Human Rabies Immunoglobulin (IM) Market Challenges

1.3.4 Human Rabies Immunoglobulin (IM) Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Human Rabies Immunoglobulin (IM) Players Revenue Ranking (2023)

2.2 Global Human Rabies Immunoglobulin (IM) Revenue by Company (2019-2024)

2.3 Global Human Rabies Immunoglobulin (IM) Players Sales Volume Ranking (2023)

2.4 Global Human Rabies Immunoglobulin (IM) Sales Volume by Company Players (2019-2024)

2.5 Global Human Rabies Immunoglobulin (IM) Average Price by Company (2019-2024)

2.6 Key Manufacturers Human Rabies Immunoglobulin (IM) Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Human Rabies Immunoglobulin (IM) Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Human Rabies Immunoglobulin (IM)

2.9 Human Rabies Immunoglobulin (IM) Market Competitive Analysis

2.9.1 Human Rabies Immunoglobulin (IM) Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Human Rabies Immunoglobulin (IM) Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Rabies Immunoglobulin (IM) as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 ERIG

3.1.2 HRIG

3.2 Global Human Rabies Immunoglobulin (IM) Sales Value by Type

3.2.1 Global Human Rabies Immunoglobulin (IM) Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Human Rabies Immunoglobulin (IM) Sales Value, by Type (2019-2030)

3.2.3 Global Human Rabies Immunoglobulin (IM) Sales Value, by Type (%) (2019-2030)

3.3 Global Human Rabies Immunoglobulin (IM) Sales Volume by Type

3.3.1 Global Human Rabies Immunoglobulin (IM) Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Human Rabies Immunoglobulin (IM) Sales Volume, by Type (2019-2030)

3.3.3 Global Human Rabies Immunoglobulin (IM) Sales Volume, by Type (%) (2019-2030)

3.4 Global Human Rabies Immunoglobulin (IM) Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Category II Exposure

4.1.2 Category III Exposure

4.2 Global Human Rabies Immunoglobulin (IM) Sales Value by Application

4.2.1 Global Human Rabies Immunoglobulin (IM) Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Human Rabies Immunoglobulin (IM) Sales Value, by Application (2019-2030)

4.2.3 Global Human Rabies Immunoglobulin (IM) Sales Value, by Application (%) (2019-2030)

4.3 Global Human Rabies Immunoglobulin (IM) Sales Volume by Application

4.3.1 Global Human Rabies Immunoglobulin (IM) Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Human Rabies Immunoglobulin (IM) Sales Volume, by Application (2019-2030)

4.3.3 Global Human Rabies Immunoglobulin (IM) Sales Volume, by Application (%) (2019-2030)

4.4 Global Human Rabies Immunoglobulin (IM) Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Human Rabies Immunoglobulin (IM) Sales Value by Region

5.1.1 Global Human Rabies Immunoglobulin (IM) Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Human Rabies Immunoglobulin (IM) Sales Value by Region (2019-2024)

5.1.3 Global Human Rabies Immunoglobulin (IM) Sales Value by Region (2025-2030)

5.1.4 Global Human Rabies Immunoglobulin (IM) Sales Value by Region (%), (2019-2030)

5.2 Global Human Rabies Immunoglobulin (IM) Sales Volume by Region

5.2.1 Global Human Rabies Immunoglobulin (IM) Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Human Rabies Immunoglobulin (IM) Sales Volume by Region (2019-2024)

5.2.3 Global Human Rabies Immunoglobulin (IM) Sales Volume by Region (2025-2030)

5.2.4 Global Human Rabies Immunoglobulin (IM) Sales Volume by Region (%), (2019-2030)

5.3 Global Human Rabies Immunoglobulin (IM) Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Human Rabies Immunoglobulin (IM) Sales Value, 2019-2030

5.4.2 North America Human Rabies Immunoglobulin (IM) Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Human Rabies Immunoglobulin (IM) Sales Value, 2019-2030

5.5.2 Europe Human Rabies Immunoglobulin (IM) Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Human Rabies Immunoglobulin (IM) Sales Value, 2019-2030

5.6.2 Asia Pacific Human Rabies Immunoglobulin (IM) Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Human Rabies Immunoglobulin (IM) Sales Value, 2019-2030

5.7.2 South America Human Rabies Immunoglobulin (IM) Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Value, 2019-2030

5.8.2 Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Human Rabies Immunoglobulin (IM) Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Human Rabies Immunoglobulin (IM) Sales Value

6.2.1 Key Countries/Regions Human Rabies Immunoglobulin (IM) Sales Value, 2019-2030

6.2.2 Key Countries/Regions Human Rabies Immunoglobulin (IM) Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Human Rabies Immunoglobulin (IM) Sales Value, 2019-2030

6.3.2 United States Human Rabies Immunoglobulin (IM) Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Human Rabies Immunoglobulin (IM) Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Human Rabies Immunoglobulin (IM) Sales Value, 2019-2030

6.4.2 Europe Human Rabies Immunoglobulin (IM) Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Human Rabies Immunoglobulin (IM) Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Human Rabies Immunoglobulin (IM) Sales Value, 2019-2030

6.5.2 China Human Rabies Immunoglobulin (IM) Sales Value by Type (%), 2023 VS 2030

6.5.3 China Human Rabies Immunoglobulin (IM) Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Human Rabies Immunoglobulin (IM) Sales Value, 2019-2030

6.6.2 Japan Human Rabies Immunoglobulin (IM) Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Human Rabies Immunoglobulin (IM) Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Human Rabies Immunoglobulin (IM) Sales Value, 2019-2030

6.7.2 South Korea Human Rabies Immunoglobulin (IM) Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Human Rabies Immunoglobulin (IM) Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Human Rabies Immunoglobulin (IM) Sales Value, 2019-2030

6.8.2 Southeast Asia Human Rabies Immunoglobulin (IM) Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Human Rabies Immunoglobulin (IM) Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Human Rabies Immunoglobulin (IM) Sales Value, 2019-2030

6.9.2 India Human Rabies Immunoglobulin (IM) Sales Value by Type (%), 2023 VS 2030

6.9.3 India Human Rabies Immunoglobulin (IM) Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 CSL Behring

7.1.1 CSL Behring Company Information

7.1.2 CSL Behring Introduction and Business Overview

7.1.3 CSL Behring Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2019-2024)

7.1.4 CSL Behring Human Rabies Immunoglobulin (IM) Product Offerings

7.1.5 CSL Behring Recent Development

7.2 Grifols

7.2.1 Grifols Company Information

7.2.2 Grifols Introduction and Business Overview

7.2.3 Grifols Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Grifols Human Rabies Immunoglobulin (IM) Product Offerings

7.2.5 Grifols Recent Development

7.3 Sanofi

7.3.1 Sanofi Company Information

7.3.2 Sanofi Introduction and Business Overview

7.3.3 Sanofi Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Sanofi Human Rabies Immunoglobulin (IM) Product Offerings

7.3.5 Sanofi Recent Development

7.4 Sichuan Yuanda Shuyang

7.4.1 Sichuan Yuanda Shuyang Company Information

7.4.2 Sichuan Yuanda Shuyang Introduction and Business Overview

7.4.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product Offerings

7.4.5 Sichuan Yuanda Shuyang Recent Development

7.5 CNBG

7.5.1 CNBG Company Information

7.5.2 CNBG Introduction and Business Overview

7.5.3 CNBG Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2019-2024)

7.5.4 CNBG Human Rabies Immunoglobulin (IM) Product Offerings

7.5.5 CNBG Recent Development

7.6 Kamada

7.6.1 Kamada Company Information

7.6.2 Kamada Introduction and Business Overview

7.6.3 Kamada Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Kamada Human Rabies Immunoglobulin (IM) Product Offerings

7.6.5 Kamada Recent Development

7.7 CBPO

7.7.1 CBPO Company Information

7.7.2 CBPO Introduction and Business Overview

7.7.3 CBPO Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2019-2024)

7.7.4 CBPO Human Rabies Immunoglobulin (IM) Product Offerings

7.7.5 CBPO Recent Development

7.8 Shuanglin Bio

7.8.1 Shuanglin Bio Company Information

7.8.2 Shuanglin Bio Introduction and Business Overview

7.8.3 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Shuanglin Bio Human Rabies Immunoglobulin (IM) Product Offerings

7.8.5 Shuanglin Bio Recent Development

7.9 Weiguang Bio

7.9.1 Weiguang Bio Company Information

7.9.2 Weiguang Bio Introduction and Business Overview

7.9.3 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Weiguang Bio Human Rabies Immunoglobulin (IM) Product Offerings

7.9.5 Weiguang Bio Recent Development

7.10 Shanghai RAAS

7.10.1 Shanghai RAAS Company Information

7.10.2 Shanghai RAAS Introduction and Business Overview

7.10.3 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Shanghai RAAS Human Rabies Immunoglobulin (IM) Product Offerings

7.10.5 Shanghai RAAS Recent Development

7.11 Bharat Serum

7.11.1 Bharat Serum Company Information

7.11.2 Bharat Serum Introduction and Business Overview

7.11.3 Bharat Serum Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Bharat Serum Human Rabies Immunoglobulin (IM) Product Offerings

7.11.5 Bharat Serum Recent Development

7.12 VINS

7.12.1 VINS Company Information

7.12.2 VINS Introduction and Business Overview

7.12.3 VINS Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2019-2024)

7.12.4 VINS Human Rabies Immunoglobulin (IM) Product Offerings

7.12.5 VINS Recent Development

8 Industry Chain Analysis

8.1 Human Rabies Immunoglobulin (IM) Industrial Chain

8.2 Human Rabies Immunoglobulin (IM) Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Human Rabies Immunoglobulin (IM) Sales Model

8.5.2 Sales Channel

8.5.3 Human Rabies Immunoglobulin (IM) Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Sichuan Yuanda Shuyang

List of Tables

Table 1. Human Rabies Immunoglobulin (IM) Market Trends

Table 2. Human Rabies Immunoglobulin (IM) Market Drivers & Opportunity

Table 3. Human Rabies Immunoglobulin (IM) Market Challenges

Table 4. Human Rabies Immunoglobulin (IM) Market Restraints

Table 5. Global Human Rabies Immunoglobulin (IM) Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Company (2019-2024)

Table 7. Global Human Rabies Immunoglobulin (IM) Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Human Rabies Immunoglobulin (IM) Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Human Rabies Immunoglobulin (IM) Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Human Rabies Immunoglobulin (IM) Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Human Rabies Immunoglobulin (IM) Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Human Rabies Immunoglobulin (IM)

Table 13. Global Human Rabies Immunoglobulin (IM) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Rabies Immunoglobulin (IM) as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Human Rabies Immunoglobulin (IM) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Human Rabies Immunoglobulin (IM) Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Human Rabies Immunoglobulin (IM) Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Human Rabies Immunoglobulin (IM) Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Human Rabies Immunoglobulin (IM) Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Human Rabies Immunoglobulin (IM) Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Human Rabies Immunoglobulin (IM) Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Human Rabies Immunoglobulin (IM) Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Human Rabies Immunoglobulin (IM) Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Human Rabies Immunoglobulin (IM) Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Human Rabies Immunoglobulin (IM) Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Human Rabies Immunoglobulin (IM) Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Human Rabies Immunoglobulin (IM) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Human Rabies Immunoglobulin (IM) Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Human Rabies Immunoglobulin (IM) Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Human Rabies Immunoglobulin (IM) Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Human Rabies Immunoglobulin (IM) Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Human Rabies Immunoglobulin (IM) Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Human Rabies Immunoglobulin (IM) Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Human Rabies Immunoglobulin (IM) Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Human Rabies Immunoglobulin (IM) Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Human Rabies Immunoglobulin (IM) Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Human Rabies Immunoglobulin (IM) Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Human Rabies Immunoglobulin (IM) Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Human Rabies Immunoglobulin (IM) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Human Rabies Immunoglobulin (IM) Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Human Rabies Immunoglobulin (IM) Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Human Rabies Immunoglobulin (IM) Sales Value by Region (2019-2024) & (%)

Table 44. Global Human Rabies Immunoglobulin (IM) Sales Value by Region (2025-2030) & (%)

Table 45. Global Human Rabies Immunoglobulin (IM) Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Human Rabies Immunoglobulin (IM) Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Human Rabies Immunoglobulin (IM) Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Human Rabies Immunoglobulin (IM) Sales Volume by Region (2019-2024) & (%)

Table 49. Global Human Rabies Immunoglobulin (IM) Sales Volume by Region (2025-2030) & (%)

Table 50. Global Human Rabies Immunoglobulin (IM) Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Human Rabies Immunoglobulin (IM) Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Human Rabies Immunoglobulin (IM) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Human Rabies Immunoglobulin (IM) Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Human Rabies Immunoglobulin (IM) Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Human Rabies Immunoglobulin (IM) Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Human Rabies Immunoglobulin (IM) Sales Volume, (2025-2030) & (K Units)

Table 57. CSL Behring Company Information

Table 58. CSL Behring Introduction and Business Overview

Table 59. CSL Behring Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. CSL Behring Human Rabies Immunoglobulin (IM) Product Offerings

Table 61. CSL Behring Recent Development

Table 62. Grifols Company Information

Table 63. Grifols Introduction and Business Overview

Table 64. Grifols Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. Grifols Human Rabies Immunoglobulin (IM) Product Offerings

Table 66. Grifols Recent Development

Table 67. Sanofi Company Information

Table 68. Sanofi Introduction and Business Overview

Table 69. Sanofi Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Sanofi Human Rabies Immunoglobulin (IM) Product Offerings

Table 71. Sanofi Recent Development

Table 72. Sichuan Yuanda Shuyang Company Information

Table 73. Sichuan Yuanda Shuyang Introduction and Business Overview

Table 74. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product Offerings

Table 76. Sichuan Yuanda Shuyang Recent Development

Table 77. CNBG Company Information

Table 78. CNBG Introduction and Business Overview

Table 79. CNBG Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. CNBG Human Rabies Immunoglobulin (IM) Product Offerings

Table 81. CNBG Recent Development

Table 82. Kamada Company Information

Table 83. Kamada Introduction and Business Overview

Table 84. Kamada Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. Kamada Human Rabies Immunoglobulin (IM) Product Offerings

Table 86. Kamada Recent Development

Table 87. CBPO Company Information

Table 88. CBPO Introduction and Business Overview

Table 89. CBPO Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. CBPO Human Rabies Immunoglobulin (IM) Product Offerings

Table 91. CBPO Recent Development

Table 92. Shuanglin Bio Company Information

Table 93. Shuanglin Bio Introduction and Business Overview

Table 94. Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. Shuanglin Bio Human Rabies Immunoglobulin (IM) Product Offerings

Table 96. Shuanglin Bio Recent Development

Table 97. Weiguang Bio Company Information

Table 98. Weiguang Bio Introduction and Business Overview

Table 99. Weiguang Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 100. Weiguang Bio Human Rabies Immunoglobulin (IM) Product Offerings

Table 101. Weiguang Bio Recent Development

Table 102. Shanghai RAAS Company Information

Table 103. Shanghai RAAS Introduction and Business Overview

Table 104. Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 105. Shanghai RAAS Human Rabies Immunoglobulin (IM) Product Offerings

Table 106. Shanghai RAAS Recent Development

Table 107. Bharat Serum Company Information

Table 108. Bharat Serum Introduction and Business Overview

Table 109. Bharat Serum Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 110. Bharat Serum Human Rabies Immunoglobulin (IM) Product Offerings

Table 111. Bharat Serum Recent Development

Table 112. VINS Company Information

Table 113. VINS Introduction and Business Overview

Table 114. VINS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 115. VINS Human Rabies Immunoglobulin (IM) Product Offerings

Table 116. VINS Recent Development

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Human Rabies Immunoglobulin (IM) Downstream Customers

Table 120. Human Rabies Immunoglobulin (IM) Distributors List

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Human Rabies Immunoglobulin (IM) Product Picture

Figure 2. Global Human Rabies Immunoglobulin (IM) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Human Rabies Immunoglobulin (IM) Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Human Rabies Immunoglobulin (IM) Sales Volume (2019-2030) & (K Units)

Figure 5. Global Human Rabies Immunoglobulin (IM) Sales Price (2019-2030) & (USD/Unit)

Figure 6. Human Rabies Immunoglobulin (IM) Report Years Considered

Figure 7. Global Human Rabies Immunoglobulin (IM) Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Human Rabies Immunoglobulin (IM) Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Rabies Immunoglobulin (IM) Revenue in 2023

Figure 10. Human Rabies Immunoglobulin (IM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. ERIG Picture

Figure 12. HRIG Picture

Figure 13. Global Human Rabies Immunoglobulin (IM) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Human Rabies Immunoglobulin (IM) Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Human Rabies Immunoglobulin (IM) Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Human Rabies Immunoglobulin (IM) Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Human Rabies Immunoglobulin (IM) Price by Type (2019-2030) & (USD/Unit)

Figure 18. Product Picture of Category II Exposure

Figure 19. Product Picture of Category III Exposure

Figure 20. Global Human Rabies Immunoglobulin (IM) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Human Rabies Immunoglobulin (IM) Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Human Rabies Immunoglobulin (IM) Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global Human Rabies Immunoglobulin (IM) Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Human Rabies Immunoglobulin (IM) Price by Application (2019-2030) & (USD/Unit)

Figure 25. North America Human Rabies Immunoglobulin (IM) Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Human Rabies Immunoglobulin (IM) Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Human Rabies Immunoglobulin (IM) Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Human Rabies Immunoglobulin (IM) Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Human Rabies Immunoglobulin (IM) Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Human Rabies Immunoglobulin (IM) Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Human Rabies Immunoglobulin (IM) Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Human Rabies Immunoglobulin (IM) Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Human Rabies Immunoglobulin (IM) Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Human Rabies Immunoglobulin (IM) Sales Volume (%), (2019-2030)

Figure 37. United States Human Rabies Immunoglobulin (IM) Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Human Rabies Immunoglobulin (IM) Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Human Rabies Immunoglobulin (IM) Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Human Rabies Immunoglobulin (IM) Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Human Rabies Immunoglobulin (IM) Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Human Rabies Immunoglobulin (IM) Sales Value by Application (%), 2023 VS 2030

Figure 43. China Human Rabies Immunoglobulin (IM) Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Human Rabies Immunoglobulin (IM) Sales Value by Type (%), 2023 VS 2030

Figure 45. China Human Rabies Immunoglobulin (IM) Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Human Rabies Immunoglobulin (IM) Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Human Rabies Immunoglobulin (IM) Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Human Rabies Immunoglobulin (IM) Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Human Rabies Immunoglobulin (IM) Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Human Rabies Immunoglobulin (IM) Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Human Rabies Immunoglobulin (IM) Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Human Rabies Immunoglobulin (IM) Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Human Rabies Immunoglobulin (IM) Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Human Rabies Immunoglobulin (IM) Sales Value by Application (%), 2023 VS 2030

Figure 55. India Human Rabies Immunoglobulin (IM) Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Human Rabies Immunoglobulin (IM) Sales Value by Type (%), 2023 VS 2030

Figure 57. India Human Rabies Immunoglobulin (IM) Sales Value by Application (%), 2023 VS 2030

Figure 58. Human Rabies Immunoglobulin (IM) Industrial Chain

Figure 59. Human Rabies Immunoglobulin (IM) Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Dengue Testing Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-26K6048

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Ebola Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-20L6129

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Cytomegalovirus Infection Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-4F6384

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global IVD Infectious Diseases Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-16N6009

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions